MHRA – Page 208 – Pharma.Tips

Tube Leakage Complaint at accelerated stability: complaint trending and risk-based actions

Investigation of Tube Leakage Complaints During Accelerated Stability Testing In pharmaceutical manufacturing, tube leakage complaints during accelerated stability testing present critical issues, possibly leading to quality defects and regulatory concerns.…

Endotoxin Oos during hold-time study: facility, people, process root cause mapping

Root Cause Analysis of Endotoxin OOS in Hold-Time Studies: A Practical Guide In the pharmaceutical manufacturing environment, Out of Specification (OOS) results can have significant implications, especially regarding endotoxin levels…

Bioburden Spike Pre-Filtration during terminal sterilization: facility, people, process root cause mapping

Identifying and Addressing Bioburden Spikes Pre-Filtration during Terminal Sterilization in Pharmaceutical Manufacturing In the pharmaceutical manufacturing industry, the integrity of terminal sterilization processes is crucial, especially regarding parenteral dosage forms.…

Emulsion Inversion during inspection preparation: how to document deviations for FDA/EMA

Managing Emulsion Inversion during Inspection Preparation: A Compliance Investigation Guide In the realm of pharmaceutical manufacturing, ensuring the integrity of your formulations is critical, especially in the context of emulsion…

Unplanned Line Stoppage during hold-time study: risk assessment for patient safety and recall

Risk Assessment for Patient Safety Following Unplanned Line Stoppage during a Hold-Time Study In pharmaceutical manufacturing, an unplanned line stoppage during a hold-time study can pose significant risks to product…

Aseptic Gowning Deviation after maintenance intervention: risk assessment for patient safety and recall

Aseptic Gowning Deviation Investigation Post-Maintenance Intervention: Ensuring Compliance and Patient Safety Aseptic processing is pivotal in pharmaceutical manufacturing, particularly for parenteral dosage forms. When deviations occur—such as an aseptic gowning…

Odor Change during method transfer: mixing and sampling controls for QA review

Investigating Odor Changes during Method Transfers: Effective Controls for Quality Assurance Review Odor changes during method transfers can signal underlying issues that compromise product quality and regulatory compliance. This article…

Em Excursion In Grade A during PAI readiness: facility, people, process root cause mapping

Identifying the Root Causes of Em Excursions in Grade A During PAI Readiness In the pharmaceutical manufacturing industry, maintaining compliance with strict standards is crucial, particularly in sterile manufacturing areas…

Bioburden Spike Pre-Filtration during routine EM trending: facility, people, process root cause mapping

Mapping the Root Causes of Bioburden Spikes in Pre-Filtration During Routine Environmental Monitoring Trending Bioburden spikes in pre-filtration during routine environmental monitoring (EM) present significant challenges for pharmaceutical manufacturers, particularly…

Texture Variability after excipient change: GMP investigation and CAPA strategy

GMP Investigation and CAPA Strategy for Texture Variability Following Excipient Changes In the dynamic environment of pharmaceutical manufacturing, excipients play a crucial role in determining the quality of dosage forms.…

Filter Integrity Failure during routine EM trending: how to classify deviation and set disposition

Addressing Filter Integrity Failures during Routine Environmental Monitoring: A Comprehensive Investigation Guide In the highly regulated environment of pharmaceutical manufacturing, the failure of filter integrity during routine environmental monitoring (EM)…

Particulate Matter Oos during routine EM trending: FDA/MHRA investigation narrative and batch impact

Understanding OOS Results for Particulate Matter in Environmental Monitoring Trends: A Structured Investigation Particulate matter (PM) unexpectedly flagged as out-of-specification (OOS) during routine environmental monitoring (EM) can cause significant concerns…